ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Virology
Volume 352, Issue 1, 15 August 2006, Pages 86-99
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (972 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.virol.2006.04.010    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Inc. All rights reserved.

Gene expression profiling of the host response to HIV-1 B, C, or A/E infection in monocyte-derived dendritic cells

Mayra Solisa, Peter Wilkinsona, Raphaelle Romieua, Eduardo Hernandeza, Mark A. Wainberga and John HiscottCorresponding Author Contact Information, a, E-mail The Corresponding Author

aMcGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Departments of Microbiology and Immunology and Medicine, McGill University, 3755 Cote Ste. Catherine, Montreal, Quebec, Canada H3T1E2

Received 1 December 2005; 
revised 17 January 2006; 
accepted 3 April 2006. 
Available online 30 May 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Dendritic cells (DC) are among the first targets of human immunodeficiency virus type-1 (HIV-1) infection and in turn play a crucial role in viral transmission to T cells and in the regulation of the immune response. The major group of HIV-1 has diversified genetically based on variation in env sequences and comprise at least 11 subtypes. Because little is known about the host response elicited against different HIV-1 clade isolates in vivo, we sought to use gene expression profiling to identify genes regulated by HIV-1 subtypes B, C, and A/E upon de novo infection of primary immature monocyte-derived DC (iMDDCs). A total of 3700 immune-related genes were subjected to a significance analysis of microarrays (SAM); 656 genes were selected as significant and were further divided into 8 functional categories. Regardless of the time of infection, 20% of the genes affected by HIV-1 were involved in signal transduction, followed by 14% of the genes identified as transcription-related genes, and 7% were classified as playing a role in cell proliferation and cell cycle. Furthermore, 7% of the genes were immune response genes. By 72 h postinfection, genes upregulated by subtype B included the inhibitor of the matrix metalloproteinase TIMP2 and the heat shock protein 40 homolog (Hsp40) DNAJB1, whereas the IFN inducible gene STAT1, the MAPK1/ERK2 kinase regulator ST5, and the chemokine CXCL3 and SHC1 genes were induced by subtypes C and A/E. These analyses distinguish a temporally regulated host response to de novo HIV-1 infection in primary dendritic cells.

Keywords: HIV-1; Gene expression; Microarray; Immune response; Dendritic cells

Article Outline

Introduction
Results
Kinetics of HIV-1 clades B, C, and A/E replication in immature DCs
Specificity of gene expression changes induced by HIV-1 subtypes B, C, and A/E
Classification of HIV-1-modulated genes into functional groups
Immediate and early genes affected by HIV-1 infection in iMDDC
Late genes affected by HIV-1 infection in iMDDC (24 and 72 h)
Discussion
Materials and methods
HIV-1 isolates
Reagents
In vitro differentiation of monocyte-derived dendritic cells (MDDC)
Infection of MDDC
Microarray experimental design
RNA isolation, amplification, and hybridization
Microarray analysis
RQ-PCR
Acknowledgements
Appendix A. Supplementary data
References








Virology
Volume 352, Issue 1, 15 August 2006, Pages 86-99
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.